Today’s Sign That We’re All F*[email protected]: Pfizer releases pill for disease that may not exist


According to the New York Times, the average patient suffering from fibromyalgia is Don Rickles.
To all sufferers of the mysterious disease fibromyalgia, we have some good news and some bad news. The good news is that a drug has just been approved for the disease. The bad news: It may not be a disease at all. Or is that the good news? Wait, what the hell’s going on? As reported in today’s New York Times, the FDA has approved Lyrica, a pill that combats pain associated with fibromyalgia. But many doctors insist that fibromyalgia is either a psychosomatic condition, or simply whiners complaining about pain natural to the human existence: "As diagnosed,” writes reporter Alex Berenson, “fibromyalgia primarily affects middle-aged women and is characterized by chronic, widespread pain of unknown origin.” In other words, doctors have no idea what it is—and for that matter, how Lyrica helps defeat it. The side effects, however—swelling, dizziness, sleepiness, and weight gain—are undoubtedly real. “The potential for weight gain is a special concern,” writes Berenson, “because many fibromyalgia patients are already overweight: the average fibromyalgia patient in the 2007 survey reported weighing 180 pounds and standing 5 feet 4 inches.” Whoa, New York Times, you can’t just sneak a tidbit like that in at the end. Are you saying the the average fibromyalgia sufferer has the dimensions of Don Rickles? Think maybe there’s a connection there? -- Gus Garcia-Roberts


We welcome readers to submit letters regarding articles and content in Cleveland Scene. Letters should be a minimum of 150 words, refer to content that has appeared on Cleveland Scene, and must include the writer's full name, address, and phone number for verification purposes. No attachments will be considered. Writers of letters selected for publication will be notified via email. Letters may be edited and shortened for space.

Email us at [email protected].

Support Local Journalism.
Join the Cleveland Scene Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the Cleveland Scene Press Club for as little as $5 a month.